Correlation Between Mink Therapeutics and Citius Oncology,
Can any of the company-specific risk be diversified away by investing in both Mink Therapeutics and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mink Therapeutics and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mink Therapeutics and Citius Oncology,, you can compare the effects of market volatilities on Mink Therapeutics and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mink Therapeutics with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mink Therapeutics and Citius Oncology,.
Diversification Opportunities for Mink Therapeutics and Citius Oncology,
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Mink and Citius is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Mink Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mink Therapeutics are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Mink Therapeutics i.e., Mink Therapeutics and Citius Oncology, go up and down completely randomly.
Pair Corralation between Mink Therapeutics and Citius Oncology,
Given the investment horizon of 90 days Mink Therapeutics is expected to generate 0.27 times more return on investment than Citius Oncology,. However, Mink Therapeutics is 3.75 times less risky than Citius Oncology,. It trades about -0.06 of its potential returns per unit of risk. Citius Oncology, is currently generating about -0.2 per unit of risk. If you would invest 99.00 in Mink Therapeutics on September 1, 2024 and sell it today you would lose (26.00) from holding Mink Therapeutics or give up 26.26% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 61.9% |
| Values | Daily Returns |
Mink Therapeutics vs. Citius Oncology,
Performance |
| Timeline |
| Mink Therapeutics |
| Citius Oncology, |
Mink Therapeutics and Citius Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mink Therapeutics and Citius Oncology,
The main advantage of trading using opposite Mink Therapeutics and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mink Therapeutics position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.| Mink Therapeutics vs. Affimed NV | Mink Therapeutics vs. Adaptimmune Therapeutics Plc | Mink Therapeutics vs. Sangamo Therapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals |
| Citius Oncology, vs. Verve Therapeutics | Citius Oncology, vs. Beam Therapeutics | Citius Oncology, vs. Caribou Biosciences | Citius Oncology, vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |